Skip to content

Pharminent

Primary Menu
  • Home
    • Pro Hub
Light/Dark Button
Hub
  • Home
  • Manufacturing
  • Innovent’s CDMO gets green light to make biologics at large Chinese plant
  • Manufacturing

Innovent’s CDMO gets green light to make biologics at large Chinese plant

BioSpace

The license, which Innovent's Altruist business said is the first of its kind, positions the CDMO to support commercial clients as it works to expand the plant's capacity to 172,000 liters.

ManufacturingRead full story

pharminent April 9, 2026 (Last updated: April 9, 2026)

BioSpace

The license, which Innovent’s Altruist business said is the first of its kind, positions the CDMO to support commercial clients as it works to expand the plant’s capacity to 172,000 liters.

ManufacturingRead full story

Post navigation

Previous: Kainova expands DT 7012 trial into Europe
Next: Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb

Related Stories

  • Manufacturing

Sandoz plans ‘vast and vertically integrated’ supply chain to support 100-biosimilar vision

pharminent September 9, 2026
  • Manufacturing

US puts $125m into personalised RNA therapy production

pharminent September 2, 2026
  • Manufacturing

Multispecifics are transforming the CDMO development architecture

pharminent August 28, 2026
  • Home
  • Contact
© 2026 All rights reserved. | ReviewNews by AF themes.